Optimising Treatment of Heart Failure – Where are we Today?

Published: 03 May 2017

  • Views:

    Views Icon 946
  • Likes:

    Heart Icon 0
Average (ratings)
No ratings
Your rating


This Satellite Symposium - Experts on the Spot session titled ‘Optimising treatment of heart failure – where are we today?’ was moderated by Frank Ruschitzka. This session provided delegates the opportunity to ask questions to the expert faculty panelists; John McMurray and John Teerlink, following the two Novartis-sponsored Satellite Symposia on acute and chronic heart failure at ESC Heart Failure 2017. Watch this video recording to hear the questions and discussions from this interactive 30 minute session.

The learning objectives for this open forum expert discussion focused on:

  • How emerging key data supporting a variety of novel therapies under evaluation in acute heart failure (AHF) may help to address unmet treatment needs in acute heart failure (AHF)
  • How to manage contemporary treatments in heart failure with reduced ejection fraction (HFrEF)

Novartis sponsored satellite symposium at Heart Failure 2017 & 4th World Congress on Acute Failure
©2017 Novartis Pharma AG, CH-4002 Basel – March 2017 – GLCM/HTF/0408